GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 226 filers reported holding GENOMIC HEALTH INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $20,000 | -89.7% | 293 | -91.3% | 0.00% | – |
| Q2 2019 | $195,000 | -98.8% | 3,356 | -98.6% | 0.00% | -100.0% |
| Q1 2019 | $16,263,000 | -8.4% | 232,171 | -15.8% | 0.04% | -16.7% |
| Q4 2018 | $17,764,000 | +26.5% | 275,805 | +38.0% | 0.05% | +45.5% |
| Q3 2018 | $14,039,000 | +17232.1% | 199,921 | +12387.3% | 0.03% | – |
| Q2 2018 | $81,000 | +88.4% | 1,601 | +15.3% | 0.00% | – |
| Q1 2018 | $43,000 | -4.4% | 1,388 | +5.6% | 0.00% | – |
| Q4 2017 | $45,000 | +4.7% | 1,314 | -2.6% | 0.00% | – |
| Q3 2017 | $43,000 | -8.5% | 1,349 | -6.0% | 0.00% | – |
| Q2 2017 | $47,000 | +9.3% | 1,435 | +5.0% | 0.00% | – |
| Q1 2017 | $43,000 | -6.5% | 1,367 | -13.5% | 0.00% | – |
| Q4 2016 | $46,000 | -20.7% | 1,581 | -21.5% | 0.00% | – |
| Q3 2016 | $58,000 | +9.4% | 2,014 | -0.9% | 0.00% | – |
| Q2 2016 | $53,000 | – | 2,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |